The Remember Me feature is an automatic login process which creates a cookie on the hard drive of your computer containing a unique identifier which ASCO.org will utilize to remember you by, thereby avoiding the need to enter username and password upon subsequent visits to ASCO.org. DO NOT select this option if you share this computer with others since transactional, personal, or member only information will be accessible by other users.

To activate the Remember Me option, click the empty check box when signing in to the site. The Remember Me functionality is deactivated at the logout.

For additional information please review our Privacy Policy.


Electronic Prescribing


What is the Medicare e-Prescribing (eRx) Incentive Program?

Section 132 of Medicare Improvements for Patients and Providers Act (MIPPA) of 2008 authorizes a new incentive program for eligible professionals who are successful electronic prescribers (E-Prescribers) as defined by the Act. The program, which will begin in January 2009, will allow physicians to receive incentive payments equal to: 2% of total Medicare Part B payments in 2009 and 2010, 1% in 2011 and 2012, and 0.5% in 2013. After 2013, the bonus program will be phased out. Eligible professionals who do not adopt e-Prescribing will face the following penalties: 1% reduction in covered Medicare Part B payments in 2012, 1.5% in 2013, and 2% in 2014 and beyond. The e-Prescribing measure 125 from the 2008 PQRI program will be used for the 2009 e-Prescribing bonus program. The measure will be removed from the 2009 PQRI program.

What must I do to become a successful electronic prescriber?

Physicians are eligible for the incentive program if at least 10% of total Medicare Part B payments come from a list of 33 office-based service codes. Also, in order to qualify physicians must successfully report that they e-prescribed or attempted to e-prescribe at least 50% of the time during these eligible situations. The incentive payment would be applied to all payments under Medicare Part B and not just for e-prescribing claims or office visits.

Therefore, physicians would report one of three G codes below as a numerator on claims with one of the 33 codes below as a denominator. The numerator codes are:

  • G8443 – to report using an e-prescribing system for all prescriptions.
  • G8445 – to report using a qualified e-prescribing system, but that you didn’t generate any prescriptions during the encounter.
  • G8446 – to report using a qualified e-prescribing system, but:
    • You didn’t e-prescribe due to state or federal law or regulations that required you to phone in or print the prescription.
    • You didn’t e-prescribe one or more prescriptions because they were for narcotics or other controlled substances.
    • The patient requested that you phone in or print the prescription.
    • The pharmacy system cannot receive electronic transmissions.

Services or patient encounters to be used as the denominators for e-prescribing include E/M visits and consultations. The CPT or HCPCS codes for the denominator are: 90801, 90802, 90804, 90805, 90806, 90807, 90808, 90809, 92002, 92004, 92012, 92014, 96150, 96151, 96152, 99201, 99202, 99203, 99204, 99205, 99211, 99212, 99213, 99214, 99215, 99241, 99242, 99243, 99244, 99245, G0101, G0108 and G0109.

Summary for successful electronic prescribing:

If you use any one of the following codes: Report one of the following codes:
90801, 90802, 90804, 90805, 90806, 90807, 90808, 90809, 92002, 92004, 92012, 92014, 96150, 96151, 96152, 99201, 99202, 99203, 99204, 99205, 99211, 99212, 99213, 99214, 99215, 99241, 99242, 99243, 99244, 99245, G0101, G0108, G0109
  • G8443 (prescription by e-prescribing)
  • G8446 (some prescriptions handwritten)
  • G8445 (no prescriptions written)*

* Note: Always use one of the codes above when e-prescribing.

 

What are some of the challenges physicians may face with this new program?

  • It is a voluntary program and so a physician may e-prescribe but the pharmacies are not obligated to accept the e-prescription.
  • No registration is required for the program and you can begin reporting for the bonus at anytime in 2009, however, physicians would need to successfully report any of three e- prescribing G codes 50% of the time during the calendar year. So physicians could conceivably wait until April 1, but they would then have to report 75% of the time or if physicians waited until July then they would report 100% of the time.
  • The estimated cost of adopting e-Prescribing is $3,000 per doctor.
  • The DEA requires an intricate system of checks and cross-checks under e-Prescribing, both human and programmed, which could require one workflow for controlled substances and another for non-controlled substances.
  • Practices with an existing EHR may find that their vendor products do not have a qualifying e-Prescribing module. Qualifying standalone systems are available and can be researched on the SureScripts website. The Certification Commission for Healthcare Information Technology (CCHIT) plans to certify standalone e-Prescribing systems in 2009.

What are the pros and cons of a standalone versus an integrated e-Prescribing system?

Standalone e-Prescribing System Integrated e-Prescribing System

Pros:

Pros:

  • One integrated system provides flexibility and convenience with minimal workflow errors and disruptions.
  • Allows for electronic access to all patient data stored in the EHR, including diagnoses, problem lists, clinical notes, laboratory and radiology results and orders.
  • Increased efficiency due to integration with practice management software for demographic info, billing and scheduling.


Cons:

  • Redundant data entry of demographic information.
  • Should the decision be made to purchase an EHR, there is the potential trouble of transferring e-prescribing data from a stand-alone into the new EHR.

Cons:

  • Significantly more expensive then the stand-alone option.
  • Return on investment a concern for small practices, rural settings, and inner city locations.

 

Other Resources






 
2318 Mill Road, Suite 800, Alexandria, VA 22314   |   phone: (571) 483-1300
© 2005-2009 American Society of Clinical Oncology (ASCO).  All rights reserved worldwide.